NCT06804044View on ClinicalTrials.gov

Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

January 24, 2024

Conditions
Polycystic Ovary SyndromeWeight LossIntermittent FastingMedical Nutrition TherapyCaloric Restriction
Interventions
BEHAVIORAL

Intermittent Fasting

A 16:8 intermittent fasting with a daytime eating window model was applied.

BEHAVIORAL

Standart Diet Therapy

Meal plan with 3 main meals and 3 snacks was applied.

Trial Locations (1)

34353

Bahçeşehir University, Istanbul

All Listed Sponsors
lead

Bahçeşehir University

OTHER